DE3200763C2 - - Google Patents

Info

Publication number
DE3200763C2
DE3200763C2 DE19823200763 DE3200763A DE3200763C2 DE 3200763 C2 DE3200763 C2 DE 3200763C2 DE 19823200763 DE19823200763 DE 19823200763 DE 3200763 A DE3200763 A DE 3200763A DE 3200763 C2 DE3200763 C2 DE 3200763C2
Authority
DE
Germany
Prior art keywords
length
fluorouracil
living body
medicament
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE19823200763
Other languages
German (de)
English (en)
Other versions
DE3200763A1 (de
Inventor
Takashi Kanazawa Ishikawa Jp Iwa
Hiroshi Oomuta Fukuoka Jp Takayanagi
Katsuya Yokohama Kanagawa Jp Sakai
Masami Hiratsuka Kanagawa Jp Asakura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsui Chemicals Inc
Original Assignee
Mitsui Toatsu Chemicals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP273781A external-priority patent/JPS57116008A/ja
Priority claimed from JP16199881A external-priority patent/JPS5865211A/ja
Application filed by Mitsui Toatsu Chemicals Inc filed Critical Mitsui Toatsu Chemicals Inc
Publication of DE3200763A1 publication Critical patent/DE3200763A1/de
Application granted granted Critical
Publication of DE3200763C2 publication Critical patent/DE3200763C2/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19823200763 1981-01-13 1982-01-13 Arzneimittel-formkoerper Granted DE3200763A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP273781A JPS57116008A (en) 1981-01-13 1981-01-13 Novel formed drug
JP16199881A JPS5865211A (ja) 1981-10-13 1981-10-13 徐放性成形制ガン剤

Publications (2)

Publication Number Publication Date
DE3200763A1 DE3200763A1 (de) 1982-11-25
DE3200763C2 true DE3200763C2 (fi) 1993-02-25

Family

ID=26336200

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19823200763 Granted DE3200763A1 (de) 1981-01-13 1982-01-13 Arzneimittel-formkoerper

Country Status (4)

Country Link
CH (1) CH650405A5 (fi)
DE (1) DE3200763A1 (fi)
FR (1) FR2497661B1 (fi)
GB (1) GB2091554B (fi)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5385738A (en) * 1983-10-14 1995-01-31 Sumitomo Pharmaceuticals Company, Ltd. Sustained-release injection
EP0139286B1 (en) * 1983-10-14 1991-08-21 Sumitomo Pharmaceuticals Company, Limited Prolonged sustained-release preparations
US4855134A (en) * 1983-10-14 1989-08-08 Sumitomo Pharmaceuticals Company, Limited Sustained-release preparation
US4774091A (en) * 1983-10-14 1988-09-27 Sumitomo Pharmaceuticals Company, Ltd. Long-term sustained-release preparation
EP0166315B1 (de) * 1984-06-19 1989-08-23 BASF Aktiengesellschaft Magensaftresistent überzogene zylindrische Pankreatin-Mikrotabletten
CA1277601C (en) * 1985-12-27 1990-12-11 Shigeji Sato Method for producing sustained release formulation
JPS63503540A (ja) * 1986-05-29 1988-12-22 フセソユーズヌイ、ナウチノ‐イスレドワーチェルスキー、イ、イスピタテルヌイ、インスチツート、メディツィンスコイ、チェフニキ 生物分解性ポリマー製の抗腫瘍性フィルム
AU606383B2 (en) * 1987-03-06 1991-02-07 Research Triangle Institute Polymer blends for selective biodegradability
ES2062634T3 (es) * 1990-08-30 1994-12-16 Senju Pharma Co Composicion con liberacion controlada del farmaco.
FR2673843B1 (fr) * 1991-03-14 1995-01-13 Centre Nat Rech Scient Composition pharmaceutique implantable, bioresorbable a base de poly(acide lactique), destinee a mettre en óoeuvre une antibiotherapie interne locale.
GB2281709B (en) * 1993-09-14 1998-04-08 Fujitsu Ltd Biodegradable resin moulded article
US5542920A (en) * 1994-09-12 1996-08-06 Delab Needle-less parenteral introduction device
US5595973A (en) 1994-09-12 1997-01-21 Biomeasure Incorporated Protection of hemopoietic cells during chemotherapy or radiotherapy
AU745055B2 (en) * 1994-09-12 2002-03-07 Delab Parenterally administered medicament
AU3634595A (en) * 1994-09-16 1996-03-29 Angus Chemical Company Bis-oxazolidines and their use
FR2756493B1 (fr) * 1996-12-02 2001-04-13 Delab Dispositif d'administration locale de formulations solides ou semi-solides
US20020111603A1 (en) 1996-12-02 2002-08-15 Societe De Conseils De Recherches Et D'application Device for local administration of solid or semi-solid formulations and delayed-release formulations for proposal parental administration and preparation process
US6485514B1 (en) * 1997-12-12 2002-11-26 Supergen, Inc. Local delivery of therapeutic agents
FR2770134B1 (fr) * 1998-10-28 2002-06-07 Delab Formulations solides ou semi-solides pour administration locale
JP2002542183A (ja) 1999-04-16 2002-12-10 ノボ ノルディスク アクティーゼルスカブ 成形可能な乾燥した医薬製剤
US8454997B2 (en) 2001-12-18 2013-06-04 Novo Nordisk A/S Solid dose micro implant
GB2446780A (en) 2007-02-22 2008-08-27 Glide Pharmaceutical Technolog An elongate parenteral injection body having an injection point of angle 10 to 40 degrees.
AU2014253541B2 (en) * 2007-02-22 2016-07-28 Glide Pharmaceutical Technologies Limited Solid pharmaceutical and vaccine dose
ES2362525B8 (es) * 2009-10-08 2013-01-03 Azurebio, S.L. Formulación de medicamentos en forma de agujas percutaneas penetrantes.
US10596330B2 (en) 2015-08-26 2020-03-24 Medtronic Xomed, Inc. Resorbable, drug-eluting submucosal turbinate implant device and method
DE102020203106A1 (de) 2020-03-11 2021-09-16 Lts Lohmann Therapie-Systeme Ag Wirkstoffstempel mit einem Insert zur schlagartigen Applikation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3887699A (en) * 1969-03-24 1975-06-03 Seymour Yolles Biodegradable polymeric article for dispensing drugs
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US3857932A (en) * 1970-09-09 1974-12-31 F Gould Dry hydrophilic acrylate or methacrylate polymer prolonged release drug implants
US4014987A (en) * 1974-06-04 1977-03-29 Alza Corporation Device for delivery of useful agent
DE2843963A1 (de) * 1978-10-09 1980-04-24 Merck Patent Gmbh Im koerper resorbierbare geformte masse auf basis von kollagen und ihre verwendung in der medizin
US4249531A (en) * 1979-07-05 1981-02-10 Alza Corporation Bioerodible system for delivering drug manufactured from poly(carboxylic acid)

Also Published As

Publication number Publication date
GB2091554B (en) 1984-09-12
GB2091554A (en) 1982-08-04
CH650405A5 (fr) 1985-07-31
DE3200763A1 (de) 1982-11-25
FR2497661B1 (fr) 1985-10-18
FR2497661A1 (fr) 1982-07-16

Similar Documents

Publication Publication Date Title
DE3200763C2 (fi)
DE3685958T2 (de) Durch ultraschall gesteuerte polymere vorrichtungen zur wirkstoffabgabe.
DE69224131T2 (de) Polymerzusammensetzungen zur Verwendung als Implantate mit verzögerter Abgabe
DE69814885T2 (de) Verfahren zur herstellung von arzneiformen mit kontrollierter wirkstoffabgabe auf polymerbasis
DE60017956T2 (de) Biodegradierbare polymerzusammensetzung
DE60111068T2 (de) Polymere verabreichungsform von leuprolid mit verbesserter wirksamkeit
DE60127822T2 (de) Komprimierte mikropartikel für trockene injektion
DE60003803T2 (de) Trockene formbare arzneistoffformulierung
EP0311065B1 (de) Implantierbares, biologisch abbaubares Wirkstofffreigabesystem
DE69331387T2 (de) Biodegradierbare polymeren matrizen mit verzoegerter freisetzung von lokalanaesthetika
DE69705746T2 (de) Injizierbare depotgelzubereitung und herstellungsverfahren
DE69728371T2 (de) Verfahren zur herstellung von implantaten, die leuprolid enthalten
DE69332210T2 (de) Biologisch abbaubares, schmelzgesponnenes abgabesystem zur kontrollierten freisetzung
DE69722440T2 (de) Plastifizierbares implantatmaterial
DE69634277T2 (de) Kontrolliertes zuführsystem mit einer flüssigkeit von hoher viskosität
DE69632569T2 (de) Formulierungen und verfahren für eine verlängerte lokalanästhesie
DE3822459C2 (de) Pharmazeutische Zusammensetzung
DE69429507T2 (de) Magnetisch reagierende zusammensetzung als träger für biologisch aktive substanzen und verfahren für ihre herstellung und verwendung
DE69326163T2 (de) Verfahren zur herstellung von arzneiformen und kontrollierte freigabe und die soerhaltenen arzneiformen
EP0281778A1 (de) Mehrteilige implantierbare Arzneizubereitung mit Langzeitwirkung
EP1519713B1 (de) Wirkstofffreisetzungssysteme auf basis von bioabbaubaren oder biokompatiblen polymeren mit formgedaechtniseffekt
DE69826451T2 (de) Anästhetischer Knochenzement
DE4031881C2 (de) Lösungsmittelfreie, oral zu verabreichende pharmazeutische Zubereitung mit verzögerter Wirkstoffreisetzung und Verfahren zu deren Herstellung
DE69621942T2 (de) Verbessertes herstellungsverfahren und zusammensetzung für therapeutisches cisplatin (cddp)
CH638987A5 (de) Langsam und gleichmaessig wirkstoffe freisetzende pharmazeutische zubereitung.

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8363 Opposition against the patent
8366 Restricted maintained after opposition proceedings
8305 Restricted maintenance of patent after opposition
D4 Patent maintained restricted
8327 Change in the person/name/address of the patent owner

Owner name: MITSUI CHEMICALS, INC., TOKIO/TOKYO, JP

8339 Ceased/non-payment of the annual fee